Janney Starts Onconova Therapeutics (ONTX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Wall St gains on bright earnings, megacaps' support
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil falls back after robust EU data as Mideast tensions linger
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- Apple, PepsiCo, JetBlue fall premarket; Amazon, GM and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
Leerink Swann Starts Onconova Therapeutics (ONTX) at Outperform
August 19, 2013 11:31 AM EDTLeerink Swann initiated coverage on Onconova Therapeutics (NASDAQ: ONTX) with an Outperform rating and a price target of $25.00. Analyst analyst Howard Liang believes risk/reward is attractive.
"Although the Phase III ONTIME readout is clearly a binary event and there is considerable... More
Citi Starts Onconova Therapeutics (ONTX) at Neutral
August 19, 2013 6:54 AM EDTCiti initiates coverage on Onconova Therapeutics (NASDAQ: ONTX) with a Neutral. PT $30.00.
For an analyst ratings summary and ratings history on Onconova Therapeutics click here. For more ratings news on Onconova Therapeutics click here.
Shares of Onconova Therapeutics closed at $25.69 yesterday, with a 52 week range of $19.42-$30.00.... More
Piper Jaffray Starts Onconova Therapeutics (ONTX) at Overweight
August 19, 2013 6:51 AM EDTPiper Jaffray initiates coverage on Onconova Therapeutics (NASDAQ: ONTX) with a Overweight. PT $38.00.
For an analyst ratings summary and ratings history on Onconova Therapeutics click here. For more ratings news on Onconova Therapeutics click here.
Shares of Onconova Therapeutics closed at $25.69 yesterday, with a 52 week range of $19.42-$30.00.... More
